5.1 Hematology & Coagulation Parameters in Safety Evaluation
Key Takeaways
- RBC, hemoglobin, and hematocrit describe red-cell mass; MCV and MCHC classify cell size and hemoglobinization, while reticulocytes decide whether an anemia is regenerative.
- A glucocorticoid-type stress leukogram is mature neutrophilia, lymphopenia, and eosinopenia without a meaningful left shift; inflammation more often adds bands, toxic change, or a demand neutropenia.
- PT screens the extrinsic and common pathways and often prolongs first in vitamin K antagonism; aPTT screens the intrinsic and common pathways; fibrinogen falls in consumption or liver-synthetic failure and rises as an acute-phase protein.
- Marrow cytology shows morphology and the myeloid-to-erythroid ratio; marrow histopathology shows cellularity, architecture, necrosis, and fibrosis—collect both when the CBC suggests production failure.
- Rats are lymphocyte-rich, dogs are neutrophil-rich with a classic stress leukogram, and nonhuman primate counts shift sharply with restraint; interpret against concurrent controls bled the same way.
Why hematology is a Domain I.C.2 skill
Handbook task I.C.2 asks whether you can interpret clinical pathology—not merely notice that a group mean is starred. Independent OpenExamPrep material in this section treats the complete blood count, reticulocyte count, leukocyte differential, platelet count, and coagulation panel as living-animal readouts of bone marrow, spleen, hemorrhage, hemolysis, inflammation, stress, and hepatic clotting-factor synthesis. A statistically significant drop in red-cell mass that is never classified as regenerative or nonregenerative is an incomplete interpretation. A “high white count” that is not distinguished as a stress leukogram versus an inflammatory leukogram will send you to the wrong target organ.
Clinical pathology is collected because morphology at necropsy can lag, and because some injuries (intravascular hemolysis, coagulopathy, sudden marrow shutdown) are easier to see in blood than on a single hematoxylin-and-eosin section. The reverse is also true: thymic cortical depletion may be obvious on the slide while the circulating lymphocyte count is only mildly changed. Integration is the skill the examination is after.
Red-cell mass: RBC, hemoglobin, and hematocrit
Red blood cell count (RBC), hemoglobin (Hgb), and hematocrit (Hct) (packed cell volume) describe circulating red-cell mass. They usually move together. Divergent patterns are flags: hemoglobin falling faster than hematocrit can occur with in-vitro hemolysis of the sample; hematocrit rising without a matching hemoglobin rise can reflect splenic contraction or dehydration concentrating cells.
Dehydration raises Hgb/Hct (hemoconcentration) and often total protein. Overhydration, pregnancy, or sampling after large fluid loads can dilute them. Serial phlebotomy in rats is a study-made anemia: the animal is not “toxic,” the protocol bled it too often. Satellite toxicokinetic animals exist partly to protect the main-study hematology.
Indices and reticulocytes: MCV, MCHC, and regeneration
Mean corpuscular volume (MCV) classifies anemia as microcytic, normocytic, or macrocytic. Mean corpuscular hemoglobin concentration (MCHC) flags hypochromia. Iron-deficiency and some chronic blood-loss states trend microcytic hypochromic. Reticulocytosis itself raises MCV because reticulocytes are larger than mature cells, so a regenerative hemolytic anemia is often macrocytic (or normocytic-macrocytic) with a high reticulocyte count. An artifactually high MCHC is a classic clue to in-vitro hemolysis or lipemia, not to “hyperchromic” toxicant cells.
Reticulocytes are the essential regenerative marker. After acute blood loss or hemolysis, the marrow needs time—often about 3–4 days in dogs—to mount a clear reticulocytosis. A day-2 bleed labeled “nonregenerative marrow toxicity” is frequently a timing error, not a stem-cell diagnosis. Young rats normally run higher reticulocyte fractions than adult dogs; use concurrent controls of the same age, not a dog textbook range.
| Parameter | What a change usually means in a safety study | Frequent confounders |
|---|---|---|
| RBC, Hgb, Hct | Decreased red-cell mass (anemia) or increased mass (erythrocytosis, hemoconcentration) | Fasting/dehydration, bleed volume, collection site, splenic contraction |
| MCV | Microcytosis (iron, fragmentation) vs macrocytosis (reticulocytes) | Reticulocytosis, agglutination artifacts, species/age |
| MCHC | Hypochromia with impaired hemoglobinization; high MCHC often artifact | Lipemia, in-vitro hemolysis |
| Reticulocytes | Marrow is responding (regenerative) or is not (nonregenerative) | Age, analyzer method, hours-to-days after hemorrhage |
| Neutrophils ± bands | Inflammation with left shift vs mature stress neutrophilia | Excitement (epinephrine), NHP capture |
| Lymphocytes / eosinophils | Stress lymphopenia and eosinopenia; lymphoid toxicity; leukemia | Age (young rats lymphocyte-rich), circadian rhythm, restraint |
| Platelets | Production failure, consumption (DIC), destruction, or reactive thrombocytosis | Clumping, underfilled EDTA tubes |
| PT, aPTT, fibrinogen | Extrinsic path, intrinsic path, and substrate/acute-phase protein | Citrate ratio, vitamin K, liver failure, inflammation raising fibrinogen |
Regenerative versus nonregenerative anemia
Regenerative anemia means the marrow is releasing young red cells: increased reticulocytes, polychromasia, often increased MCV, sometimes nucleated RBCs. Causes in toxicology include hemorrhage (gastrointestinal ulcers, coagulopathy, protocol blood sampling) and hemolysis (immune-mediated, oxidative/Heinz-body, microangiopathic). Look at bilirubin, plasma discoloration, and spleen histopathology (erythrophagocytosis, hemosiderin) to separate hemolysis from external blood loss. External hemorrhage does not raise total bilirubin the way hemolysis can.
Nonregenerative anemia means production is failing or is not yet visible: low or inappropriately normal reticulocytes. Causes include direct marrow toxicity, anemia of chronic inflammation, chronic kidney disease (erythropoietin deficit), late iron deficiency, and pure red-cell aplasia. Nonregenerative anemia plus neutropenia and thrombocytopenia (pancytopenia) pushes you to marrow, not to a solitary gastrointestinal ulcer. Do not call every low hematocrit “bone-marrow toxicity.” Classify regeneration first, then name the mechanism.
Leukocytes: stress leukograms versus inflammation
A stress leukogram (glucocorticoid-type) is typically mature neutrophilia, lymphopenia, eosinopenia, and in dogs often monocytosis, without a clinically meaningful left shift or toxic change. Endogenous cortisol from shipping, repeated handling, or a test article with glucocorticoid activity can produce it. Epinephrine/excitement leukocytosis is more neutrophilia plus lymphocytosis from demargination and splenic contraction and is common at difficult bleeds.
An inflammatory leukogram shows neutrophilia that may include band neutrophils (left shift), toxic change, monocytosis as inflammation becomes chronic, and sometimes neutropenia if demand outstrips marrow supply (overwhelming inflammation or marrow failure). Absolute counts matter more than percentages: a lymphopenic rat can still have a “normal-looking” percentage if neutrophils crash too.
Lymphopenia with thymic and splenic lymphoid depletion may be stress, direct immunotoxicity, or infection. The blood film and the lymphoid organs have to be read together; the count alone does not award the mechanism.
Platelets and coagulation: PT, aPTT, fibrinogen
Thrombocytopenia may be decreased production (marrow), consumption (disseminated intravascular coagulation (DIC)), immune destruction, or sequestration (spleen). Platelet clumps cause false-low automated counts—consider a smear. Reactive thrombocytosis follows inflammation or rebound after recovery.
Prothrombin time (PT) screens the extrinsic and common pathways (factor VII plus X, V, II, fibrinogen). Factor VII has a short half-life, so vitamin K antagonism (anticoagulant rodenticides, some gut-flora disruptions in coprophagic species, cholestasis impairing vitamin K absorption) often prolongs PT first.
Activated partial thromboplastin time (aPTT) screens the intrinsic and common pathways (XII, XI, IX, VIII, then common). Heparin-like activity and intrinsic-factor deficits prolong aPTT more prominently.
Fibrinogen is both clotting substrate and a positive acute-phase protein. It falls in DIC, massive consumption, and severe hepatic synthetic failure. It rises with inflammation—so a “normal” fibrinogen in a clearly inflamed animal can mean concurrent consumption. Interpret fibrinogen with PT, aPTT, and platelets, not as a lone number.
Underfilled citrate tubes (too much citrate for the plasma volume) artifactually prolong PT and aPTT. Rodent volumes make this a routine technical failure, not a test-article effect. The usual citrate ratio is 9 parts blood to 1 part citrate; short fills invert that chemistry.
Bone-marrow cytology versus histopathology
When hematology is abnormal, marrow evaluation is not optional storytelling. Cytology (femur or sternum smears) gives nuclear and cytoplasmic detail, a myeloid-to-erythroid (M:E) ratio, maturation sequence, dysplasia, and stainable iron in some species. It is poor at judging overall cellularity because smear thickness varies, and it misses fibrosis, necrosis architecture, and focal lesions.
Histopathology of sternum and/or femur (with bone) gives cellularity, architecture, stroma, necrosis, myelofibrosis, and infiltrates. It is weaker for subtle dysplasia and differential counts. Many programs collect both when the protocol anticipates hematologic toxicity. A cytology-only “hypocellular” call without a histologic cellularity estimate is not a complete marrow diagnosis.
Species notes: rat versus dog versus nonhuman primate
Rat. Lymphocytes normally dominate the differential (often on the order of three-quarters of leukocytes in young adults). A neutrophilia that would look modest in a dog can be a large relative shift in a rat. Blood volume is small; repeated bleeds create iatrogenic anemia. Extramedullary hematopoiesis in spleen is common and increases with demand. Male rats develop chronic progressive nephropathy that can secondarily affect erythropoiesis later in life—more a chronic-study confounder than a 14-day finding.
Dog. Neutrophils usually dominate. The glucocorticoid stress leukogram, including monocytosis, is textbook. Dogs are large enough for repeat sampling and for high-quality coagulation samples if venipuncture is clean. Some Beagle colonies have had factor VII deficiency as a background finding—know the colony before you call a prolonged PT a test-article effect.
Nonhuman primate (NHP). Differentials are more neutrophil-rich than the rat and more human-like, but capture, chairing, and ketamine restraint produce large, acute shifts: neutrophilia, lymphopenia, hyperglycemia, and creatine kinase from struggle. Acclimation and consistent handling matter more than in rodents. Menstruation can lower red-cell mass in females. Interpret NHP hematology against concurrent controls bled the same way, not against a resting human CBC.
Integration with marrow, spleen, and thymus histopathology
Hematology is a living-animal assay of organs you will later weigh and section. Marrow explains production failure and some leukemias. Spleen explains sequestration, extramedullary hematopoiesis, erythrophagocytosis, and lymphoid change. Thymus (especially in young rodents) is a sensitive lymphoid organ: physiologic involution with age and stress involution both reduce cortex; dose-related cortical depletion plus peripheral lymphopenia plus lack of recovery may support immunotoxicity rather than cage-stress alone. Do not diagnose “immunosuppression” from a stress leukogram without the lymphoid organs, body-weight context, and, when relevant, recovery data.
Scenario
A 28-day oral rat study shows high-dose males with Hgb 11.2 g/dL versus control 14.8 g/dL, MCV increased, reticulocytes clearly increased, bilirubin slightly up, and spleen weights up with histologic hemosiderin and erythrophagocytosis. Marrow histology is hypercellular in the erythroid line. That package is regenerative hemolytic anemia, not primary marrow failure. Calling it bone-marrow toxicity because anemia is present would invert the mechanism.
If instead Hgb is low, reticulocytes are low, neutrophils and platelets are also low, and marrow histology is hypocellular, you are in myelosuppression—and cytology should confirm whether remaining cells are dysplastic or simply scarce.
Traps
- Treating a day-1 post-bleed anemia as nonregenerative marrow toxicity.
- Calling every neutrophilia “infection.”
- Ignoring citrate underfilling as the cause of prolonged PT/aPTT in rats.
- Using dog differential expectations on a rat CBC.
- Skipping marrow histology when the CBC shows pancytopenia.
Which CBC pattern is a classic glucocorticoid-type stress leukogram in the dog?
On day 10 of a rat oral study, high-dose animals have low hemoglobin, increased MCV, clearly increased reticulocytes, a mild bilirubin increase, and splenic hemosiderin with erythrophagocytosis. How should the anemia be classified?
A 13-week study shows pancytopenia. Why would a pathologist collect both bone-marrow cytology and bone-marrow histopathology?